Home Casteddu.com FAQ My Amedeo About Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Prostate Cancer

  Free Subscription


Articles published in Prostate

Retrieve available abstracts of 303 articles:
HTML format

Single Articles


    July 2009
  1. CLEMENTI M , Sanchez C, Benitez DA, Contreras HR, et al
    Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Prostate. 2009;69:1025-33.
    PubMed     Related articles    Abstract available


    June 2009
  2. KIM MH , Fields J
    Translationally regulated C/EBPbeta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
    Prostate. 2009;69:1256.
    PubMed     Related articles   


  3. ATTARD G , Rizzo S, Ledaki I, Clark J, et al
    A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  4. GIBBS TC , Rubio MV, Zhang Z, Xie Y, et al
    Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  5. GOODYEAR SM , Kheyfets SB, Garcia FU, Stearns ME, et al
    Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.
    Prostate. 2009;69:982-90.
    PubMed     Related articles    Abstract available


  6. MURTOLA TJ , Pennanen P, Syvala H, Blauer M, et al
    Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
    Prostate. 2009;69:1017-23.
    PubMed     Related articles    Abstract available


  7. SHIGEMURA K , Isotani S, Wang R, Fujisawa M, et al
    Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
    Prostate. 2009;69:949-55.
    PubMed     Related articles    Abstract available


  8. BOSE SK , Gibson W, Giri S, Nath N, et al
    Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  9. EMAMI KH , Brown LG, Pitts TE, Sun X, et al
    Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  10. GATTI G , Quintar AA, Andreani V, Nicola JP, et al
    Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  11. SANCHEZ C , Mendoza P, Contreras HR, Vergara J, et al
    Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  12. BRUSA D , Migliore E, Garetto S, Simone M, et al
    Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  13. MONTORSI F , Alcaraz A, Desgrandchamps F, Hammerer P, et al
    A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
    Prostate. 2009;69:895-907.
    PubMed     Related articles    Abstract available


  14. SVATEK RS , Jeldres C, Karakiewicz PI, Suardi N, et al
    Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
    Prostate. 2009;69:886-94.
    PubMed     Related articles    Abstract available


  15. KAWASAKI BT , Hurt EM, Kalathur M, Duhagon MA, et al
    Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.
    Prostate. 2009;69:827-37.
    PubMed     Related articles    Abstract available


  16. KIM MH , Minton AZ, Agrawal V
    C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  17. PETRIGLIANO FA , Virk MS, Liu N, Sugiyama O, et al
    Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


    May 2009
  18. TSUNODA T , Furusato B, Takashima Y, Ravulapalli S, et al
    The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  19. NICOTERA TM , Schuster DP, Bourhim M, Chadha K, et al
    Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  20. SCHENK JM , Kristal AR, Neuhouser ML, Tangen CM, et al
    Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  21. PAYNE SR , Serth J, Schostak M, Kamradt J, et al
    DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  22. JOHANSSON M , McKay JD, Rinaldi S, Wiklund F, et al
    Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  23. MORRISON C , Cheney R, Johnson CS, Smith G, et al
    Central quadrant procurement of radical prostatectomy specimens.
    Prostate. 2009;69:770-3.
    PubMed     Related articles    Abstract available


  24. RICCIARDELLI C , Sakko AJ, Stahl J, Tilley WD, et al
    Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
    Prostate. 2009;69:761-9.
    PubMed     Related articles    Abstract available


  25. GARDNER CD , Oelrich B, Liu JP, Feldman D, et al
    Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
    Prostate. 2009;69:719-26.
    PubMed     Related articles    Abstract available


  26. YEH IT , Reddick RL, Kumar AP
    Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Prostate. 2009;69:755-60.
    PubMed     Related articles    Abstract available


  27. GOODYEAR SM , Amatangelo MD, Stearns ME
    Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
    Prostate. 2009;69:689-98.
    PubMed     Related articles    Abstract available


  28. RONQUIST KG , Ronquist G, Carlsson L, Larsson A, et al
    Human prostasomes contain chromosomal DNA.
    Prostate. 2009;69:737-43.
    PubMed     Related articles    Abstract available


  29. RAVENNA L , Sale P, Di Vito M, Russo A, et al
    Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  30. IZUMI K , Mizokami A, Li YQ, Narimoto K, et al
    Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  31. KADER AK , Sun J, Isaacs SD, Wiley KE, et al
    Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  32. LEMAN ES , Magheli A, Cannon GW, Mangold L, et al
    Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  33. PANG B , Zhang H, Wang J, Chen WZ, et al
    Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  34. VYKHOVANETS EV , Shukla S, MacLennan GT, Vykhovanets OV, et al
    Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.
    Prostate. 2009;69:633-43.
    PubMed     Related articles    Abstract available


  35. LIU CM , Lo YC, Tai MH, Wu BN, et al
    Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Prostate. 2009;69:610-23.
    PubMed     Related articles    Abstract available


  36. LIU T , Wu LY, Choi JK, Berkman CE, et al
    In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.
    Prostate. 2009;69:585-94.
    PubMed     Related articles    Abstract available


  37. HANSEL DE , Nakayama M, Luo J, Abukhdeir AM, et al
    Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
    Prostate. 2009;69:603-9.
    PubMed     Related articles    Abstract available


    April 2009
  38. JANTSCHEFF P , Esser N, Graeser R, Ziroli V, et al
    Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  39. KARSENTY G , Rocha J, Chevalier S, Scarlata E, et al
    Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells In Vitro and In Vivo.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  40. JENNBACKEN K , Gustavsson H, Tesan T, Horn M, et al
    The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: An effect influenced by testosterone.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  41. LIU C , Hasegawa K, Russell SJ, Sadelain M, et al
    Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  42. MALINOWSKA K , Cavarretta IT, Susani M, Wrulich OA, et al
    Identification of micro-crystallin as an androgen-regulated gene in human prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  43. ISHKANIAN AS , Mallof CA, Ho J, Meng A, et al
    High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  44. YIN H , Lowery M, Glass J
    In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  45. JAYADEVAPPA R , Chhatre S, Wein AJ, Malkowicz SB, et al
    Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  46. KELA I , Harmelin A, Waks T, Orr-Urtreger A, et al
    Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  47. ANANIAS HJ , van den Heuvel MC, Helfrich W, de Jong IJ, et al
    Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  48. DOZMOROV MG , Hurst RE, Culkin DJ, Kropp BP, et al
    Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  49. SUN Y , Goodison S
    Optimizing molecular signatures for predicting prostate cancer recurrence.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  50. JOHN K , Ragavan N, Pratt MM, Singh PB, et al
    Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.
    Prostate. 2009;69:505-19.
    PubMed     Related articles    Abstract available


  51. PARSONS JK , Saria EA, Nakayama M, Vessella RL, et al
    Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells.
    Prostate. 2009;69:559-69.
    PubMed     Related articles    Abstract available


  52. MLCOCHOVA P , Barinka C, Tykvart J, Sacha P, et al
    Prostate-specific membrane antigen and its truncated form PSM'.
    Prostate. 2009;69:471-9.
    PubMed     Related articles    Abstract available


  53. KISS P , Eltoum IE, Suranyi P, Zeng H, et al
    Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.
    Prostate. 2009;69:449-58.
    PubMed     Related articles    Abstract available


    March 2009
  54. BENITEZ DA , Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM, et al
    Regulation of cell survival by resveratrol involves inhibition of NFkappaB-regulated gene expression in prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  55. ISAYEVA T , Moore LD, Chanda D, Chen D, et al
    Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  56. MONSEF N , Soller M, Isaksson M, Abrahamsson PA, et al
    The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  57. FLEISCHMANN A , Schlomm T, Kollermann J, Sekulic N, et al
    Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  58. WANG MH , Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, et al
    Association of IL10 and Other immune response- and obesity-related genes with prostate cancer in CLUE II.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  59. WATSON SK , Woolcock BW, Fee JN, Bainbridge TC, et al
    Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  60. ZHAO H , Peehl DM
    Tumor-promoting phenotype of CD90(hi) prostate cancer-associated fibroblasts.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  61. INOUE T , Maeno A, Talbot C Jr, Zeng Y, et al
    Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  62. FEYERABEND S , Stevanovic S, Gouttefangeas C, Wernet D, et al
    Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  63. KIM S , Lee JB, Lee GK, Chang J, et al
    Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  64. RAY AM , Zuhlke KA, Levin AM, Douglas JA, et al
    Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  65. LOCKE JA , Fazli L, Adomat H, Smyl J, et al
    A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  66. JARIWALA U , Cogan JP, Jia L, Frenkel B, et al
    Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.
    Prostate. 2009;69:392-400.
    PubMed     Related articles    Abstract available


  67. SOTOMAYOR P , Godoy A, Smith GJ, Huss WJ, et al
    Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
    Prostate. 2009;69:401-10.
    PubMed     Related articles    Abstract available


    February 2009
  68. MA C , Yoshioka M, Boivin A, Gan L, et al
    Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
    Prostate. 2009;69:293-316.
    PubMed     Related articles    Abstract available


  69. BONORDEN MJ , Rogozina OP, Kluczny CM, Grossmann ME, et al
    Cross-sectional analysis of intermittent versus chronic caloric restriction in the TRAMP mouse.
    Prostate. 2009;69:317-26.
    PubMed     Related articles    Abstract available


  70. HAFFNER J , Potiron E, Bouye S, Puech P, et al
    Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology.
    Prostate. 2009;69:276-82.
    PubMed     Related articles    Abstract available


  71. YU X , Wang Y, Jiang M, Bierie B, et al
    Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
    Prostate. 2009;69:249-62.
    PubMed     Related articles    Abstract available


  72. PALAPATTU GS , Wu C, Silvers CR, Martin HB, et al
    Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  73. WIKSTROM P , Marusic J, Stattin P, Bergh A, et al
    Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  74. FERNANDEZ-MARTINEZ AB , Bajo AM, Sanchez-Chapado M, Prieto JC, et al
    Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  75. WALTON TJ , Li G, McCulloch TA, Seth R, et al
    Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  76. HONG SK , Lee ST, Kim SS, Min KE, et al
    Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  77. DEEB D , Gao X, Jiang H, Dulchavsky SA, et al
    Oleanane Triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  78. THOMAS F , Patel S, Holly JM, Persad R, et al
    Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.
    Prostate. 2009;69:219-24.
    PubMed     Related articles    Abstract available


  79. LEE SO , Chun JY, Nadiminty N, Lou W, et al
    Interleukin-4 activates androgen receptor through CBP/p300.
    Prostate. 2009;69:126-32.
    PubMed     Related articles    Abstract available


  80. NARAYANAN NK , Nargi D, Horton L, Reddy BS, et al
    Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
    Prostate. 2009;69:133-41.
    PubMed     Related articles    Abstract available


    January 2009
  81. PEANT B , Diallo JS, Dufour F, Le Page C, et al
    Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  82. ZHANG X , Wang W, True LD, Vessella RL, et al
    Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  83. WAKCHOURE S , Swain TM, Hentunen TA, Bauskin AR, et al
    Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  84. LANDRISCINA M , Bagala C, Piscazzi A, Schinzari G, et al
    Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  85. KOH YT , Gray A, Higgins SA, Hubby B, et al
    Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  86. LEIN M , Miller K, Wirth M, Weissbach L, et al
    Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  87. TAKAHASHI S , Takeshita K, Seeni A, Sugiura S, et al
    Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  88. DEHAAN AM , Wolters NM, Keller ET, Ignatoski KM, et al
    EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  89. MO Z , Gao Y, Cao Y, Gao F, et al
    An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: A HuGE Review.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  90. THOMAS LN , Douglas RC, Rittmaster RS, Too CK, et al
    Overexpression of 5alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.
    Prostate. 2009.
    PubMed     Related articles    Abstract available


  91. BOUYE S , Potiron E, Puech P, Leroy X, et al
    Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.
    Prostate. 2009;69:105-13.
    PubMed     Related articles    Abstract available


  92. FORSBERG O , Carlsson B, Malmstrom PU, Ullenhag G, et al
    High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Prostate. 2009;69:70-81.
    PubMed     Related articles    Abstract available


  93. COX ME , Gleave ME, Zakikhani M, Bell RH, et al
    Insulin receptor expression by human prostate cancers.
    Prostate. 2009;69:33-40.
    PubMed     Related articles    Abstract available


    December 2008
  94. WIKLUND F , Zheng SL, Sun J, Adami HO, et al
    Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  95. LU Q , Zhang J, Allison R, Gay H, et al
    Identification of extracellular delta-catenin accumulation for prostate cancer detection.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  96. CHU JH , Yu S, Hayward SW, Chan FL, et al
    Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  97. SAKAI Y , Goodison S, Kusmartsev S, Fletcher B, et al
    Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  98. GROSS M , Ramirez C, Luthringer D, Nepomuceno E, et al
    Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  99. MINELLI A , Bellezza I, Tucci A, Rambotti MG, et al
    Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  100. MURALIMANOHARAN SB , Kunnumakkara AB, Shylesh B, Kulkarni KH, et al
    Butanol fraction containing berberine or related compound from nexrutine(R) inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  101. TEZVAL H , Jurk S, Atschekzei F, Serth J, et al
    The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  102. SALINAS CA , Koopmeiners JS, Kwon EM, Fitzgerald L, et al
    Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  103. NADIMINTY N , Chun JY, Lou W, Lin X, et al
    NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
    Prostate. 2008;68:1725-33.
    PubMed     Related articles    Abstract available


    November 2008
  104. LANGE EM , Beebe-Dimmer JL, Ray AM, Zuhlke KA, et al
    Genome-wide linkage scan for prostate cancer susceptibility from the university of michigan prostate cancer genetics project: Suggestive evidence for linkage at 16q23.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  105. CHENG Y , Kim JW, Liu W, Dunn TA, et al
    Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  106. ZENG Y , Kakehi Y, Nouh MA, Tsunemori H, et al
    Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  107. YASUDA K , Nagakawa O, Akashi T, Fujiuchi Y, et al
    Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  108. LU Y , Zhang X, Beheshti B, Zhang J, et al
    Adenoviral-mediated pHyde Gene Transfer and Cisplatin Additively Inhibit Human Prostate Cancer Growth by Enhancing Apoptosis.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  109. THOMAS R , Kim MH
    A HIF-1alpha-dependent autocrine feedback loop promotes survival of serum-deprived prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  110. FLEISCHMANN A , Schobinger S, Schumacher M, Thalmann GN, et al
    Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  111. FESTUCCIA C , Gravina GL, Muzi P, Millimaggi D, et al
    Her2 crosstalks with TrkA in a subset of prostate cancer cells: Rationale for a guided dual treatment.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  112. KRANSE R , Roobol M, Schroder FH
    A graphical device to represent the outcomes of a logistic regression analysis.
    Prostate. 2008;68:1674-80.
    PubMed     Related articles    Abstract available


  113. SCHWARZE SR , Lin EW, Christian PA, Gayheart DT, et al
    Intracellular death platform steps-in: targeting prostate tumors via endoplasmic reticulum (ER) apoptosis.
    Prostate. 2008;68:1615-23.
    PubMed     Related articles    Abstract available


    October 2008
  114. SCHAFER SC , Pfnur M, Yerly S, Fandel TM, et al
    Cryopreservation of prostate cancer tissue during routine processing of fresh unfixed prostatectomy specimen: demonstration and validation of a new technique.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  115. BHAMRE S , Sahoo D, Tibshirani R, Dill DL, et al
    Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  116. MSAOUEL P , Iankov ID, Allen C, Morris JC, et al
    Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  117. KNIGHT D , Peterson AC, Rini BI, Harlin H, et al
    The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  118. STEPHAN C , Kahrs AM, Cammann H, Lein M, et al
    A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  119. GRAHAM TR , Odero-Marah VA, Chung LW, Agrawal KC, et al
    PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  120. KELLY MP , Lee ST, Lee FT, Smyth FE, et al
    Therapeutic efficacy of (177)Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  121. ARNOLD RS , Sun CQ, Richards JC, Grigoriev G, et al
    Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  122. MUBIRU JN , Hubbard GB, Dick EJ Jr, Furman J, et al
    Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases.
    Prostate. 2008;68:1546-54.
    PubMed     Related articles    Abstract available


  123. MUMENTHALER SM , Rozengurt N, Livesay JC, Sabaghian A, et al
    Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Prostate. 2008;68:1561-9.
    PubMed     Related articles    Abstract available


    September 2008
  124. YANG L , Gaikwad NW, Meza J, Cavalieri EL, et al
    Novel biomarkers for risk of prostate cancer: Results from a case-control study.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  125. MORI R , Xiong S, Wang Q, Tarabolous C, et al
    Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  126. KOBAYASHI M , Ishida H, Shindo T, Niwa SI, et al
    Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  127. SCARIANO JK , Treat E, Alba F, Nelson H, et al
    The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  128. SHI XB , Xue L, Zou JX, Gandour-Edwards R, et al
    Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  129. VAN NIEKERK CG , van der Laak JA, Borger ME, Huisman HJ, et al
    Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  130. NAITO M , Itoh K, Komatsu N, Yamashita Y, et al
    Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  131. DIPAOLA RS , Dvorzhinski D, Thalasila A, Garikapaty V, et al
    Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  132. VELTRI RW , Isharwal S, Miller MC, Epstein JI, et al
    Long-Term assessment of prostate cancer progression free survival: Evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  133. ROBBINS CM , Hernandez W, Ahaghotu C, Bennett J, et al
    Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


    August 2008
  134. WANG T , Alavian MR, Goel HL, Languino LR, et al
    Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  135. HEINRICH E , Schally AV, Buchholz S, Rick FG, et al
    Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  136. AALINKEEL R , Bindukumar B, Reynolds JL, Sykes DE, et al
    The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  137. CROSS NA , Fowles A, Reeves K, Jokonya N, et al
    Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  138. RACLAW KA , Heemers HV, Kidd EM, Dehm SM, et al
    Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  139. TERADA N , Tsuchiya N, Ma Z, Shimizu Y, et al
    Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  140. SAHA B , Kaur P, Tsao-Wei D, Naritoku WY, et al
    Unmethylated E-Cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  141. STOCK DC , Groome PA, Siemens DR, Rohland SL, et al
    Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  142. TERANISHI JI , Ishiguro H, Hoshino K, Noguchi K, et al
    Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  143. VAN GILS MP , Hessels D, Hulsbergen-van de Kaa CA, Witjes JA, et al
    Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
    Prostate. 2008;68:1215-22.
    PubMed     Related articles    Abstract available


  144. KOISTINEN H , Wohlfahrt G, Mattsson JM, Wu P, et al
    Novel small molecule inhibitors for prostate-specific antigen.
    Prostate. 2008;68:1143-51.
    PubMed     Related articles    Abstract available


  145. ZHANG J , Wilkinson JE, Gonit M, Keck R, et al
    Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.
    Prostate. 2008;68:1206-14.
    PubMed     Related articles    Abstract available


  146. DOBOSY JR , Fu VX, Desotelle JA, Srinivasan R, et al
    A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
    Prostate. 2008;68:1187-95.
    PubMed     Related articles    Abstract available


    July 2008
  147. REAGAN-SHAW S , Nihal M, Ahsan H, Mukhtar H, et al
    Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  148. JOSSON S , Sung SY, Lao K, Chung LW, et al
    Radiation modulation of MicroRNA in prostate cancer cell lines.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  149. SHAIKH IA , Brown I, Schofield AC, Wahle KW, et al
    Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF-kappaB pathway.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  150. SINGH P , Hallur G, Anchoori RK, Bakare O, et al
    Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  151. HARAM KM , Peltier HJ, Lu B, Bhasin M, et al
    Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  152. NEUWIRT H , Arias MC, Puhr M, Hobisch A, et al
    Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  153. BERG A , Bruland OS, Fossa SD, Nesland JM, et al
    Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  154. MORI R , Wang Q, Danenberg KD, Pinski JK, et al
    Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  155. SHER DJ , Oh WK, Jacobus S, Regan MM, et al
    Relationship between serum adiponectin and prostate cancer grade.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  156. BINDUKUMAR B , Schwartz S, Aalinkeel R, Mahajan S, et al
    Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  157. CHEN YC , Page JH, Chen R, Giovannucci E, et al
    Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  158. KAUR R , Yuan X, Lu ML, Balk SP, et al
    Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins.
    Prostate. 2008.
    PubMed     Related articles    Abstract available


  159. CHADHA MK , Ashraf U, Lawrence D, Tian L, et al
    Phase II study of fulvestrant (faslodex(R)) in castration resistant prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  160. NEUHOUSER ML , Schenk J, Song YJ, Tangen CM, et al
    Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  161. PETTAWAY CA , Song R, Wang X, Sanchez-Ortiz R, et al
    The ratio of matrix metalloproteinase to E-cadherin expression: A pilot study to assess mRNA and protein expression among African American prostate cancer patients.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  162. FALL K , Stark JR, Mucci LA, Chan J, et al
    No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  163. HO LL , Kench JG, Handelsman DJ, Scheffer GL, et al
    Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  164. WEERASINGHE P , Li Y, Guan Y, Zhang R, et al
    T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  165. GOLOVINE K , Uzzo RG, Makhov P, Crispen PL, et al
    Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  166. MOON JS , Lee MY, Park SW, Han WK, et al
    Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  167. TEICHERT F , Verschoyle RD, Greaves P, Edwards RE, et al
    Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
    Prostate. 2008;68:1035-47.
    PubMed     Related articles    Abstract available


  168. KURODA K , Horiguchi A, Asano T, Asano T, et al
    Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores.
    Prostate. 2008;68:1057-63.
    PubMed     Related articles    Abstract available


    June 2008
  169. THOMAS R , Kim MH
    HIF-1alpha: A key survival factor for serum-deprived prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  170. HALL CL , Daignault SD, Shah RB, Pienta KJ, et al
    Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  171. HARRIS TJ , Hipkiss EL, Borzillary S, Wada S, et al
    Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  172. MARKS RA , Zhang S, Montironi R, McCarthy RP, et al
    Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Prostate. 2008;68:919-23.
    PubMed     Related articles    Abstract available


  173. SHEPHERD CJ , Rizzo S, Ledaki I, Davies M, et al
    Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
    Prostate. 2008;68:1007-24.
    PubMed     Related articles    Abstract available


  174. CORTESI M , Fridman E, Volkov A, Shilstein SSh, et al
    Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study.
    Prostate. 2008;68:994-1006.
    PubMed     Related articles    Abstract available


  175. LIU T , Wu LY, Kazak M, Berkman CE, et al
    Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen.
    Prostate. 2008;68:955-64.
    PubMed     Related articles    Abstract available


  176. LI W , Liu X, Wang W, Sun H, et al
    Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  177. POLASCIK TJ , Mayes JM, Sun L, Madden JF, et al
    Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: Implications for unilateral ablative therapy.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  178. WEI S , Dunn TA, Isaacs WB, De Marzo AM, et al
    GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  179. FITZGERALD LM , Thomson R, Polanowski A, Patterson B, et al
    Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: A replication study in an ethnically homogeneous population.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  180. FUJITA K , Ewing CM, Sokoll LJ, Elliott DJ, et al
    Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.
    Prostate. 2008;68:872-82.
    PubMed     Related articles    Abstract available


  181. HALLSTROM TM , Laiho M
    Genetic changes and DNA damage responses in the prostate.
    Prostate. 2008;68:902-18.
    PubMed     Related articles    Abstract available


  182. BAO BY , Chuang BF, Wang Q, Sartor O, et al
    Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.
    Prostate. 2008;68:839-48.
    PubMed     Related articles    Abstract available


    May 2008
  183. HAYASHI N , Koller E, Fazli L, Gleave ME, et al
    Effects of Eg5 knockdown on human prostate cancer xenograft growth and chemosensitivity.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  184. KIM MH , Field J
    Translationally regulated C/EBPbeta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  185. LAI TH , Fong YC, Fu WM, Yang RS, et al
    Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  186. PETERNAC D , Klima I, Cecchini MG, Schwaninger R, et al
    Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  187. STEVENS VL , Rodriguez C, Talbot JT, Pavluck AL, et al
    Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  188. THOMPSON M , Lapointe J, Choi YL, Ong DE, et al
    Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  189. RYAN CJ , Zavodovskaya M, Youngren JF, Campbell M, et al
    Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  190. SUN J , Chang BL, Isaacs SD, Wiley KE, et al
    Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  191. KAWAI N , Futakuchi M, Yoshida T, Ito A, et al
    Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone.
    Prostate. 2008;68:784-92.
    PubMed     Related articles    Abstract available


  192. BERNOULLI J , Yatkin E, Laakso A, Anttinen M, et al
    Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Prostate. 2008;68:728-39.
    PubMed     Related articles    Abstract available


  193. CAO W , Yacoub S, Shiverick KT, Namiki K, et al
    Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  194. THUDI NK , Martin CK, Nadella MV, Fernandez SA, et al
    Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  195. WHITAKER HC , Girling J, Warren AY, Leung H, et al
    Alterations in beta-catenin expression and localization in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  196. KIBEL AS , Jin CH, Klim A, Luly J, et al
    Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  197. PRUEITT RL , Yi M, Hudson RS, Wallace TA, et al
    Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  198. ISHARWAL S , Miller MC, Marlow C, Makarov DV, et al
    p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  199. PIERCE BL , Plymate S, Ostrander EA, Stanford JL, et al
    Diabetes mellitus and prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  200. MASSONER P , Haag P, Seifarth C, Jurgeit A, et al
    Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: Local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  201. RAMBERG H , Eide T, Krobert KA, Levy FO, et al
    Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  202. MARUYAMA-TAKAHASHI K , Shimada N, Imada T, Maekawa-Tokuda Y, et al
    A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
    Prostate. 2008;68:640-50.
    PubMed     Related articles    Abstract available


  203. TSUI KH , Hsieh WC, Lin MH, Chang PL, et al
    Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Prostate. 2008;68:610-9.
    PubMed     Related articles    Abstract available


    April 2008
  204. BERTILACCIO MT , Grioni M, Sutherland BW, Degl'innocenti E, et al
    Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  205. ABRIL J , de Heredia ML, Gonzalez L, Cleries R, et al
    Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  206. GOSSELAAR C , Kranse R, Roobol MJ, Roemeling S, et al
    The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  207. WU Z , Gioeli D, Conaway M, Weber MJ, et al
    Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  208. MEHRAEIN-GHOMI F , Lee E, Church DR, Thompson TA, et al
    JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  209. INOUE T , Leman ES, Yeater DB, Getzenberg RH, et al
    The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  210. AGEMY L , Harmelin A, Waks T, Leibovitch I, et al
    Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
    Prostate. 2008;68:530-9.
    PubMed     Related articles    Abstract available


  211. JEET V , Ow K, Doherty E, Curley B, et al
    Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Prostate. 2008;68:548-62.
    PubMed     Related articles    Abstract available


  212. ZENZMAIER C , Untergasser G, Hermann M, Dirnhofer S, et al
    Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Prostate. 2008;68:540-7.
    PubMed     Related articles    Abstract available


    March 2008
  213. JIANG M , Li M, Fu X, Huang Y, et al
    Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  214. TROYER DA , Tang Y, Bedolla R, Adhvaryu SG, et al
    Characterization of PacMetUT1, a recently isolated human prostate cancer cell line.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  215. HORIGUCHI A , Zheng R, Shen R, Nanus DM, et al
    Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  216. SUN J , Purcell L, Gao Z, Isaacs SD, et al
    Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  217. MORGAN TM , Pitts TE, Gross TS, Poliachik SL, et al
    RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  218. FESTUCCIA C , Gravina GL, Muzi P, Millimaggi D, et al
    Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  219. IGNATOSKI KM , Escara-Wilke JF, Dai JL, Lui A, et al
    RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  220. RICCIARDELLI C , Jackson MW, Choong CS, Stahl J, et al
    Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  221. JIA L , Yu W, Wang P, Sanders BG, et al
    In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  222. WANG W , Rayburn ER, Hao M, Zhao Y, et al
    Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  223. GRAVINA GL , Festuccia C, Millimaggi D, Dolo V, et al
    Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  224. MACOSKA JA , Begley LA, Dunn RL, Siddiqui J, et al
    Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
    Prostate. 2008;68:442-52.
    PubMed     Related articles    Abstract available


  225. MINELLI A , Bellezza I, Tucci A, Conte C, et al
    2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells.
    Prostate. 2008;68:360-72.
    PubMed     Related articles    Abstract available


  226. RUNDLE A , Neugut AI
    Obesity and screening PSA levels among men undergoing an annual physical exam.
    Prostate. 2008;68:373-80.
    PubMed     Related articles    Abstract available


  227. PALMER J , Venkateswaran V, Fleshner NE, Klotz LH, et al
    The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate.
    Prostate. 2008;68:345-53.
    PubMed     Related articles    Abstract available


    February 2008
  228. CHO KS , Lee JS, Cho NH, Park K, et al
    Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  229. NEELEY YC , Arredouani MS, Hollenbeck B, Eng MH, et al
    Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  230. GOODWIN AC , Jadallah S, Toubaji A, Lecksell K, et al
    Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  231. ALLMEN EU , Koch M, Fritz G, Legler DF, et al
    V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  232. D'ANTONIO JM , Ma C, Monzon FA, Pflug BR, et al
    Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  233. AGALLIU I , Suuriniemi M, Prokunina-Olsson L, Johanneson B, et al
    Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  234. CHOW L , Rezmann L, Imamura K, Wang L, et al
    Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  235. ANGELUCCI A , Muzi P, Cristiano L, Millimaggi D, et al
    Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  236. TISCHKOWITZ M , Sabbaghian N, Ray AM, Lange EM, et al
    Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  237. MABJEESH NJ , Shefler A, Amir S, Matzkin H, et al
    Potentiation of 2-Methoxyestradiol-Induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  238. BERRY LJ , Au GG, Barry RD, Shafren DR, et al
    Potent Oncolytic activity of human enteroviruses against human prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  239. MORIKAWA A , Varma V, Gillespie TW, Lyles RH, et al
    Counting alleles in single lesions of prostate tumors from ethnically diverse patients.
    Prostate. 2008;68:231-40.
    PubMed     Related articles    Abstract available


  240. OLSSON M , Lindstrom S, Haggkvist B, Adami HO, et al
    The UGT2B17 gene deletion is not associated with prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  241. SERDA RE , Bisoffi M, Thompson TA, Ji M, et al
    1alpha,25-Dihydroxyvitamin D(3) down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  242. STROM SS , Yamamura Y, Flores-Sandoval FN, Pettaway CA, et al
    Prostate cancer in Mexican-Americans: Identification of risk factors.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  243. KUNDU SD , Lee C, Billips BK, Habermacher GM, et al
    The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells.
    Prostate. 2008;68:223-9.
    PubMed     Related articles    Abstract available


  244. MOORE ML , Teitell MA, Kim Y, Watabe T, et al
    Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation.
    Prostate. 2008;68:139-51.
    PubMed     Related articles    Abstract available


  245. VAN WIJNGAARDEN E , Singer EA, Palapattu GS
    Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey.
    Prostate. 2008;68:122-8.
    PubMed     Related articles    Abstract available


    January 2008
  246. PIENTA KJ , Abate-Shen C, Agus DB, Attar RM, et al
    The current state of preclinical prostate cancer animal models.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  247. SUN J , Lange EM, Isaacs SD, Liu W, et al
    Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  248. SERKOVA NJ , Gamito EJ, Jones RH, O'Donnell C, et al
    The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  249. GREGORAKIS AK , Stefanakis S, Malovrouvas D, Petraki K, et al
    Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  250. AITCHISON AA , Veerakumarasivam A, Vias M, Kumar R, et al
    Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  251. MU Z , Hachem P, Hensley H, Stoyanova R, et al
    Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  252. KAUSHAL A , Myers SA, Dong Y, Lai J, et al
    A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  253. DANFORTH KN , Rodriguez C, Hayes RB, Sakoda LC, et al
    TNF polymorphisms and prostate cancer risk.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  254. SUN A , Tang J, Hong Y, Song J, et al
    Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  255. LAI CL , van den Ham R, van Leenders G, van der Lugt J, et al
    Histopathological and immunohistochemical characterization of canine prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  256. SROKA IC , McDaniel K, Nagle RB, Bowden GT, et al
    Differential localization of MT1-MMP in human prostate cancer tissue: Role of IGF-1R in MT1-MMP expression.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  257. JIA L , Yu W, Wang P, Li J, et al
    Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  258. MIZUMACHI T , Muskhelishvili L, Naito A, Furusawa J, et al
    Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text


  259. LIU JW , Nagpal JK, Jeronimo C, Lee JE, et al
    Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  260. SHEA PR , Ishwad CS, Bunker CH, Patrick AL, et al
    RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  261. NARITA S , Tsuchiya N, Saito M, Inoue T, et al
    Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
    Prostate. 2008;.
    PubMed     Related articles    Abstract available


  262. ARMSTRONG AP , Miller RE, Jones JC, Zhang J, et al
    RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Prostate. 2008;68:92-104.
    PubMed     Related articles    Abstract available


  263. GUPTA A , Wang Y, Browne C, Kim S, et al
    Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Prostate. 2008;68:50-60.
    PubMed     Related articles    Abstract available


  264. LOCKE JA , Wasan KM, Nelson CC, Guns ES, et al
    Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
    Prostate. 2008;68:20-33.
    PubMed     Related articles    Abstract available


    December 2007
  265. ZHU ML , Partin JV, Bruckheimer EM, Strup SE, et al
    TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  266. SARMA AV , Dunn RL, Lange LA, Ray A, et al
    Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: The Flint Men's Health Study.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  267. SFANOS KS , Sauvageot J, Fedor HL, Dick JD, et al
    A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  268. SHAIDA N , Launchbury R, Boddy JL, Jones C, et al
    Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  269. LANGSENLEHNER T , Langsenlehner U, Renner W, Kapp KS, et al
    The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  270. HELLSTEN R , Johansson M, Dahlman A, Dizeyi N, et al
    Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  271. SONG Y , Tangen C, Goodman P, Parnes HL, et al
    Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  272. BRYANT RJ , Winder SJ, Cross SS, Hamdy FC, et al
    The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  273. WALTON TJ , Li G, Seth R, McArdle SE, et al
    DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  274. MAKAROV DV , Marlow C, Epstein JI, Miller MC, et al
    Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  275. ZHIGANG Z , Wenlu S
    The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  276. GUSTAVSSON H , Jennbacken K, Welen K, Damber JE, et al
    Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  277. THORPE JA , Christian PA, Schwarze SR
    Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  278. BETHEL CR , Bieberich CJ
    Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model.
    Prostate. 2007;67:1740-50.
    PubMed     Related articles    Abstract available


  279. QIAO Y , Zhang ZK, Cai LQ, Tan C, et al
    17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
    Prostate. 2007;67:1719-28.
    PubMed     Related articles    Abstract available


    November 2007
  280. MEHROTRA J , Varde S, Wang H, Chiu H, et al
    Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  281. WOLF P , Alt K, Buhler P, Katzenwadel A, et al
    Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  282. CHIU FL , Lin JK
    Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  283. MERSEBURGER AS , Kramer MW, Hennenlotter J, Simon P, et al
    Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  284. SAHA B , Arase A, Imam SS, Tsao-Wei D, et al
    Overexpression of E-cadherin and beta-Catenin proteins in metastatic prostate cancer cells in bone.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  285. LEE SO , Pinder E, Chun JY, Lou W, et al
    Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  286. HIGUCHI T , Nakamura M, Shimada K, Ishida E, et al
    HRK inactivation associated with promoter methylation and LOH in prostate cancer.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  287. ELLINGER J , Haan K, Heukamp LC, Kahl P, et al
    CpG Island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  288. FREEDLAND SJ , Mavropoulos J, Wang A, Darshan M, et al
    Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  289. LEROUX ME , Auzenne E, Evans R, Hail N Jr, et al
    Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
    Prostate. 2007;67:1699-717.
    PubMed     Related articles    Abstract available


  290. GARCIA FU , Haber MM, Chen X
    Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Prostate. 2007;67:1686-92.
    PubMed     Related articles    Abstract available


    October 2007
  291. EBELT K , Babaryka G, Figel AM, Pohla H, et al
    Dominance of CD4(+) lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  292. WANG D , Lu S, Dong Z
    Regulation of TGF-beta1 gene transcription in human prostate cancer cells by nitric oxide.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  293. TARAROVA ND , Narizhneva N, Krivokrisenko V, Gudkov AV, et al
    Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity.
    Prostate. 2007;.
    PubMed     Related articles    Abstract available


  294. PARK SE , Park JW, Cho YS, Ryu JH, et al
    HIF-1alpha promotes survival of prostate cells at a high zinc environment.
    Prostate. 2007;67:1514-23.
    PubMed     Related articles    Abstract available


    September 2007
  295. PARIS PL , Sridharan S, Scheffer A, Tsalenko A, et al
    High resolution oligonucleotide CGH using DNA from archived prostate tissue.
    Prostate. 2007;67:1447-55.
    PubMed     Related articles    Abstract available


  296. MEMARI N , Diamandis EP, Earle T, Campbell A, et al
    Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Prostate. 2007;67:1465-74.
    PubMed     Related articles    Abstract available


  297. OLSSON M , Gustafsson O, Skogastierna C, Tolf A, et al
    Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
    Prostate. 2007;67:1439-46.
    PubMed     Related articles    Abstract available


  298. BROWN MD , Gilmore PE, Hart CA, Samuel JD, et al
    Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
    Prostate. 2007;67:1384-96.
    PubMed     Related articles    Abstract available


  299. PRESCOTT J , Jariwala U, Jia L, Cogan JP, et al
    Androgen receptor-mediated repression of novel target genes.
    Prostate. 2007;67:1371-83.
    PubMed     Related articles    Abstract available


  300. STANGELBERGER A , Schally AV, Zarandi M, Heinrich E, et al
    The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
    Prostate. 2007;67:1339-53.
    PubMed     Related articles    Abstract available


  301. WIKSTROM P , Ohlson N, Stattin P, Bergh A, et al
    Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
    Prostate. 2007;67:1277-84.
    PubMed     Related articles    Abstract available


    January 2007
  302. SCIARRA A , Lichtner M, Autran GA, Mastroianni C, et al
    Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients.
    Prostate. 2007;67:1-7.
    PubMed     Related articles    Abstract available


  303. OHLSON N , Bergh A, Stattin P, Wikstrom P, et al
    Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels.
    Prostate. 2007;67:32-40.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: